These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 36629068

  • 1. Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model.
    Lim S, Park JH, Chang H.
    Investig Clin Urol; 2023 Jan; 64(1):74-81. PubMed ID: 36629068
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model.
    Wang H, He X, Fang D, Wang X, Guan J, Shi ZW, Chen X.
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101853. PubMed ID: 34923183
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer.
    Zhang P, Wang J, Wang D, Wang H, Shan F, Chen L, Hou Y, Wang E, Lu CL.
    Int Immunopharmacol; 2012 Nov; 14(3):252-60. PubMed ID: 22884511
    [Abstract] [Full Text] [Related]

  • 6. Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice.
    Xin B, Yang M, Wu P, Du L, Deng X, Hui E, Feng GS.
    Hepatology; 2022 Sep; 76(3):630-645. PubMed ID: 34860431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a 177Lu-labeled αPD-L1 antibody.
    Ren J, Xu M, Chen J, Ding J, Wang P, Huo L, Li F, Liu Z.
    Theranostics; 2021 Sep; 11(1):304-315. PubMed ID: 33391476
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
    Prasad M, Zorea J, Jagadeeshan S, Shnerb AB, Mathukkada S, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yegodayev KM, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstein O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Conde-Lopez C, Hess J, Kurth I, Morris LGT, Saintigny P, Elkabets M.
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
    [Abstract] [Full Text] [Related]

  • 11. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
    Minnar CM, Chariou PL, Horn LA, Hicks KC, Palena C, Schlom J, Gameiro SR.
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
    [Abstract] [Full Text] [Related]

  • 12. CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation.
    Reyes RM, Zhang C, Deng Y, Ji N, Mukherjee N, Padron AS, Clark CA, Svatek RS, Curiel TJ.
    Oncoimmunology; 2021 Jun; 10(1):2006529. PubMed ID: 34858732
    [Abstract] [Full Text] [Related]

  • 13. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal.
    Lee H, Park HJ, Sohn HJ, Kim JM, Kim SJ.
    J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303
    [Abstract] [Full Text] [Related]

  • 14. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L, Luo R, Onyshchenko K, Rao X, Wang M, Menz B, Gaedicke S, Grosu AL, Firat E, Niedermann G.
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [Abstract] [Full Text] [Related]

  • 15. PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect.
    Wen X, Zeng X, Cheng X, Zeng X, Liu J, Zhang Y, Li Y, Chen H, Huang J, Guo Z, Chen X, Zhang X.
    Mol Pharm; 2022 Oct 03; 19(10):3612-3622. PubMed ID: 35652897
    [Abstract] [Full Text] [Related]

  • 16. PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Shi X, Zhang X, Li J, Mo L, Zhao H, Zhu Y, Hu Z, Gao J, Tan W.
    Int J Cancer; 2018 May 15; 142(10):2106-2117. PubMed ID: 29243219
    [Abstract] [Full Text] [Related]

  • 17. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z, Wang H, Meng F, Li J, Zhang S.
    J Transl Med; 2015 Jul 29; 13():247. PubMed ID: 26219551
    [Abstract] [Full Text] [Related]

  • 18. Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice.
    Liu G, Zhang Z, Wu Y, Feng J, Lan Y, Dong D, Liu Y, Yuan H, Tai G, Li S, Ni W.
    Int Immunopharmacol; 2023 Aug 29; 121():110487. PubMed ID: 37364328
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.
    Crosby EJ, Acharya CR, Haddad AF, Rabiola CA, Lei G, Wei JP, Yang XY, Wang T, Liu CX, Wagner KU, Muller WJ, Chodosh LA, Broadwater G, Hyslop T, Shepherd JH, Hollern DP, He X, Perou CM, Chai S, Ashby BK, Vincent BG, Snyder JC, Force J, Morse MA, Lyerly HK, Hartman ZC.
    Clin Cancer Res; 2020 Sep 01; 26(17):4670-4681. PubMed ID: 32732224
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M, Itonaga I, Iwasaki T, Tsumura H.
    Oncol Rep; 2013 Mar 01; 29(3):1001-6. PubMed ID: 23291864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.